Online citations, reference lists, and bibliographies.
← Back to Search

Immune Gene Expression Profiling Of PBMC Isolated From Horses Vaccinated With Attenuated African Horsesickness Virus Serotype 4.

A. Pretorius, F.E. Faber, M. van Kleef
Published 2016 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Development of African horsesickness (AHS) subunit vaccines will have to include a rational approach that uses knowledge of how the virus interacts with the host immune system. The global in vivo immune response induced by attenuated AHSV serotype 4 in horses was characterised using transcriptome sequencing. PBMC were collected with 24h intervals for four days after inoculation and four days after a second boost, 21 days later. Transcriptome data were normalised to the day 0 naïve transcriptome and up- or down-regulated immune genes identified using the CLC workbench. Peak expression was observed 24h after each inoculation. Innate immunity was up-regulated after both inoculations and was characterised by type-1 interferon activation via the RIG-1/MDA5 pathway and the up-regulation of complement cascade components. After the second boost an adaptive immune response could be identified that included the production of cytokines indicative of T helper (Th)1, Th2 and Th17 responses.
This paper references
Interferon-gamma: an overview of signals, mechanisms and functions.
K. Schroder (2004)
10.1016/j.vetimm.2012.01.016
Virus-specific CD8⁺ T-cells detected in PBMC from horses vaccinated against African horse sickness virus.
Alri Pretorius (2012)
10.1016/j.vetimm.2012.06.009
An African horse sickness virus serotype 4 recombinant canarypox virus vaccine elicits specific cell-mediated immune responses in horses.
H. El Garch (2012)
10.1016/j.vetimm.2008.09.028
Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.
M. Figueiredo (2009)
10.1016/j.virusres.2013.12.002
Vaccination of mice with a modified Vaccinia Ankara (MVA) virus expressing the African horse sickness virus (AHSV) capsid protein VP2 induces virus neutralising antibodies that confer protection against AHSV upon passive immunisation.
Eva Calvo-Pinilla (2014)
Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus ( AHSV ) VP 2
Eva Calvo-Pinilla (2015)
10.4049/jimmunol.1200571
Multiple Redundant Effector Mechanisms of CD8+ T Cells Protect against Influenza Infection
H. Hamada (2013)
10.1016/S0264-410X(01)00445-5
The protective efficacy of a recombinant VP2-based African horsesickness subunit vaccine candidate is determined by adjuvant.
M. Scanlen (2002)
10.4049/jimmunol.169.5.2712
Eotaxin (CCL11) and Eotaxin-2 (CCL24) Induce Recruitment of Eosinophils, Basophils, Neutrophils, and Macrophages As Well As Features of Early- and Late-Phase Allergic Reactions Following Cutaneous Injection in Human Atopic and Nonatopic Volunteers1
A. Menzies-Gow (2002)
10.1051/VETRES:2004021
African horse sickness.
P. Mellor (1998)
10.1189/jlb.0603252
Interferon‐γ: an overview of signals, mechanisms and functions
K. Schroder (2004)
Protective immunization
R. Nordgren (2009)
10.1016/j.vaccine.2014.04.036
Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge
Berta Alberca (2014)
10.1016/j.cytogfr.2010.04.002
IL-28A, IL-28B, and IL-29: promising cytokines with type I interferon-like properties.
K. Witte (2010)
Cytokine responses to EHV1 infection in immune and nonimmune ponies
D. K. oombs (2006)
10.1158/1940-6207.CAPR-11-0212
Characterizing the Impact of Smoking and Lung Cancer on the Airway Transcriptome Using RNA-Seq
J. Beane (2011)
10.1016/j.virusres.2013.10.027
Induction and control of the type I interferon pathway by Bluetongue virus
D. Vitour (2014)
10.1016/j.vetmic.2014.10.006
Study of the virulence of serotypes 4 and 9 of African horse sickness virus in IFNAR(-/-), Balb/C and 129 Sv/Ev mice.
Maria Ana de la Grandière (2014)
10.1006/VIRO.1993.1537
Neutralizing epitopes of African horsesickness virus serotype 4 are located on VP2.
T. G. Burrage (1993)
10.3748/WJG.14.7149
Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection.
J. Larrubia (2008)
10.1016/j.vaccine.2014.07.031
Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus
Y. Kanai (2014)
10.1128/JVI.01235-14
Dual Modulation of Type I Interferon Response by Bluetongue Virus
V. Doceul (2014)
10.4049/jimmunol.1301454
IL-21–Producing Th Cells in Immunity and Autoimmunity
S. Liu (2013)
10.1016/j.ijid.2012.05.640
Sensing and control of Bluetongue virus infection in epithelial cells via RIG-I and MDA5 helicases
Emilie Chauveau (2012)
10.1016/j.chom.2014.03.003
Neutrophils Recruited by IL-22 in Peripheral Tissues Function as TRAIL-Dependent Antiviral Effectors against MCMV
Maria A. Stacey (2014)
An African horse
L. Lemaitre (2012)
10.1111/j.1365-2915.2009.00829.x
The oral susceptibility of South African field populations of Culicoides to African horse sickness virus
G. Venter (2009)
10.1038/cmi.2011.38
A critical role of IL-17 in modulating the B-cell response during H5N1 influenza virus infection
X. Wang (2011)
10.1016/J.VETIMM.2006.01.013
Cytokine responses to EHV-1 infection in immune and non-immune ponies.
D. Coombs (2006)
10.1371/journal.pone.0041645
Deep Sequencing-Based Transcriptome Analysis of Chicken Spleen in Response to Avian Pathogenic Escherichia coli (APEC) Infection
Q. Nie (2012)
10.4049/jimmunol.173.5.3013
Constitutive Expression of CCR7 Directs Effector CD8 T Cells into the Splenic White Pulp and Impairs Functional Activity1
H. Unsoeld (2004)
10.1084/jem.20111171
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
M. Caskey (2011)
10.1084/jem.20101664
Type I interferon: friend or foe?
G. Trinchieri (2010)
10.1016/S0165-2427(02)00274-X
The effect of strenuous exercise on mRNA concentrations of interleukin-12, interferon-gamma and interleukin-4 in equine pulmonary and peripheral blood mononuclear cells.
D. Ainsworth (2003)
10.1006/METH.2001.1260
Real-time quantitative PCR.
Thomas D. Schmittgen (2001)
10.1128/JVI.78.14.7528-7535.2004
CC Chemokine Receptor 7 Expression by Effector/Memory CD4+ T Cells Depends on Antigen Specificity and Tissue Localization during Influenza A Virus Infection
G. Debes (2004)
A modified vaccinia
S. Maan (2011)
10.1016/j.vaccine.2009.05.044
Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus.
A. Guthrie (2009)
10.1086/379196
Toll-like receptor and cytokine expression patterns of CD56+ T cells are similar to natural killer cells in response to infection with Venezuelan equine encephalitis virus replicons.
K. U. Saikh (2003)
10.1161/01.ATV.0000095360.62479.1F
Fractalkine in Vascular Biology: From Basic Research to Clinical Disease
H. Umehara (2004)
10.1371/journal.pone.0121015
De Novo Transcriptomic Analysis of Peripheral Blood Lymphocytes from the Chinese Goose: Gene Discovery and Immune System Pathway Description
M. Tariq (2015)
10.1371/journal.pone.0016503
A Modified Vaccinia Ankara Virus (MVA) Vaccine Expressing African Horse Sickness Virus (AHSV) VP2 Protects Against AHSV Challenge in an IFNAR −/− Mouse Model
J. Castillo-Olivares (2011)
10.1128/JVI
p21 Restricts HIV-1 in Monocyte-Derived Dendritic Cells through the Reduction of Deoxynucleoside Triphosphate Biosynthesis and Regulation of SAMHD1 Antiviral Activity VIRUS-CELL INTERACTIONS crossm
J. Valle-Casuso (2017)
10.1006/VIRO.1996.0304
Immunization with VP2 is sufficient for protection against lethal challenge with African horsesickness virus Type 4.
M. Stone-Marschat (1996)
10.1016/j.virusres.2013.09.040
The immune response of ruminant livestock to bluetongue virus: from type I interferon to antibody.
N. J. Maclachlan (2014)
Ns1 is a key protein
J. Castillo-Olivares (2013)
Study of the virulence
É Mathijs (2014)
10.1016/j.virol.2012.09.012
Anti-viral CD8 T cells and the cytokines that they love.
M. Cox (2013)
10.4049/jimmunol.1100917
IL-17 Boosts Proinflammatory Outcome of Antiviral Response in Human Cells
G. Ryzhakov (2011)
10.1371/journal.pone.0070197
Ns1 Is a Key Protein in the Vaccine Composition to Protect Ifnar(−/−) Mice against Infection with Multiple Serotypes of African Horse Sickness Virus
Francisco de la Poza (2013)
10.1099/VIR.0.83391-0
Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures.
R. Randall (2008)
CC chemokine receptor 7 expression by effector / memory CD 4 + T cells depends on antigen specificity and tissue localization during influenza A virus infection
G. F. ebes (2004)
10.1007/BF02970145
Viral mimicry of the complement system
John Bernet (2008)
10.1016/j.vetimm.2008.10.303
Genomic and non-genomic effects of dexamethasone on equine peripheral blood neutrophils.
L. Lecoq (2009)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar